Cart
sales@molnova.com
MLKL-IN-2
CAS No. 899759-16-1
MLKL-IN-2( —— )
Catalog No. M35245 CAS No. 899759-16-1
MLKL-IN-2 is an MLKL inhibitor with potential tumorigenic activity for the study of cellular necrosis-related diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 128 | Get Quote |
|
| 5MG | 188 | Get Quote |
|
| 10MG | 312 | Get Quote |
|
| 25MG | 625 | Get Quote |
|
| 50MG | 984 | Get Quote |
|
| 100MG | 1485 | Get Quote |
|
| 200MG | 2007 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMLKL-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionMLKL-IN-2 is an MLKL inhibitor with potential tumorigenic activity for the study of cellular necrosis-related diseases.
-
DescriptionMLKL-IN-2 is a MLKL inhibitor extracted from patent WO2021224505A1, compound (i).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetMLK
-
RecptorMLK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number899759-16-1
-
Formula Weight423.51
-
Molecular FormulaC26H25N5O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 10 mg/mL (23.61 mM; Ultrasonic (<60°C)
-
SMILESCN1CCN(CC1)c1ccc(nn1)-c1cccc(NC(=O)c2ccc3ccccc3c2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sáez AJG, et, al. Modulation of mixed lineage kinase domain-like protein signaling. WO2021224505A1.
molnova catalog
related products
-
GW 806742X
A small molecule MLKL (Mixed Lineage Kinase Domain-Like) interactor that binds the MLKL pseudokinase domain (Kd=9.3 uM).
-
URMC-099
URMC-099 is a potent, orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3 (MLK3) with IC50 of 14 nM.
-
M-443
A specific, irreversible inhibitor of MLK-related kinase MRK (ZAK).
